Novo Nordisk Human Insulin Injectables Facility, Chartres, France

Features: 

• Sterile parenteral formulation and filling facility for production of small volume injectables
• Batch sizes 500l to 1200l
• Class C and Class B/A Clean room suites for dispensing, preparation, crystallisation and filling
• Equipment includes weigh booths with LAFs, jacketed vessels on load cells, mobile vessels, sterile filters (hydrophobic and hydrophilic), specialist pumps and automated valve manifold design
• SCADA/PLC control system
• Fully automated formulation and ‘islands’ of machine automation for component washing/sterilising, filling and packaging
• Complex and flexible automated CIP/SIP system simultaneously supplies different washes at different temperatures to several systems
• Design meets the requirements of ISA S88 Batch Terminology Standard and GAMP
• Provision for materials handling, storage and despatch, administration and QC laboratories
• Multi-office project team